203 related articles for article (PubMed ID: 21790682)
1. Systematic review: the pathophysiology and management of polycystic liver disease.
Temmerman F; Missiaen L; Bammens B; Laleman W; Cassiman D; Verslype C; van Pelt J; Nevens F
Aliment Pharmacol Ther; 2011 Oct; 34(7):702-13. PubMed ID: 21790682
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of polycystic liver disease.
Gevers TJ; Drenth JP
Nat Rev Gastroenterol Hepatol; 2013 Feb; 10(2):101-8. PubMed ID: 23296249
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a polycystic liver disease complaint-specific assessment (POLCA).
Temmerman F; Dobbels F; Ho TA; Pirson Y; Vanslembrouck R; Coudyzer W; Bammens B; van Pelt J; Pirenne J; Nevens F
J Hepatol; 2014 Nov; 61(5):1143-50. PubMed ID: 24996047
[TBL] [Abstract][Full Text] [Related]
4. An update on the pathophysiology and management of polycystic liver disease.
Wong MY; McCaughan GW; Strasser SI
Expert Rev Gastroenterol Hepatol; 2017 Jun; 11(6):569-581. PubMed ID: 28317394
[TBL] [Abstract][Full Text] [Related]
5. Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management.
Cnossen WR; Drenth JP
Orphanet J Rare Dis; 2014 May; 9():69. PubMed ID: 24886261
[TBL] [Abstract][Full Text] [Related]
6. Surgical management of polycystic liver disease.
Russell RT; Pinson CW
World J Gastroenterol; 2007 Oct; 13(38):5052-9. PubMed ID: 17876869
[TBL] [Abstract][Full Text] [Related]
7. Management of polycystic liver disease.
Cheung J; Scudamore CH; Yoshida EM
Can J Gastroenterol; 2004 Nov; 18(11):666-70. PubMed ID: 15565206
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin analogues for treatment of polycystic liver disease.
Gevers TJ; Drenth JP
Curr Opin Gastroenterol; 2011 May; 27(3):294-300. PubMed ID: 21191289
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.
Abu-Wasel B; Walsh C; Keough V; Molinari M
World J Gastroenterol; 2013 Sep; 19(35):5775-86. PubMed ID: 24124322
[TBL] [Abstract][Full Text] [Related]
10. Polycystic Kidney/Liver Disease.
Roediger R; Dieterich D; Chanumolu P; Deshpande P
Clin Liver Dis; 2022 May; 26(2):229-243. PubMed ID: 35487607
[TBL] [Abstract][Full Text] [Related]
11. Lanreotide Reduces Liver Volume, But Might Not Improve Muscle Wasting or Weight Loss, in Patients With Symptomatic Polycystic Liver Disease.
Temmerman F; Ho TA; Vanslembrouck R; Coudyzer W; Billen J; Dobbels F; van Pelt J; Bammens B; Pirson Y; Nevens F
Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2353-9.e1. PubMed ID: 26073493
[TBL] [Abstract][Full Text] [Related]
12. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.
Hoevenaren IA; Wester R; Schrier RW; McFann K; Doctor RB; Drenth JP; Everson GT
Liver Int; 2008 Feb; 28(2):264-70. PubMed ID: 17927714
[TBL] [Abstract][Full Text] [Related]
13. Polycystic liver disease is genetically heterogeneous: clinical and linkage studies in eight Finnish families.
Tahvanainen P; Tahvanainen E; Reijonen H; Halme L; Kääriäinen H; Höckerstedt K
J Hepatol; 2003 Jan; 38(1):39-43. PubMed ID: 12480558
[TBL] [Abstract][Full Text] [Related]
14. Polycystic liver disease: a clinical review.
Chandok N
Ann Hepatol; 2012; 11(6):819-26. PubMed ID: 23109444
[TBL] [Abstract][Full Text] [Related]
15. Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1.
Reynolds DM; Falk CT; Li A; King BF; Kamath PS; Huston J; Shub C; Iglesias DM; Martin RS; Pirson Y; Torres VE; Somlo S
Am J Hum Genet; 2000 Dec; 67(6):1598-604. PubMed ID: 11047756
[TBL] [Abstract][Full Text] [Related]
16. Advances in management of polycystic liver disease.
Everson GT; Helmke SM; Doctor B
Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):563-76. PubMed ID: 19072404
[TBL] [Abstract][Full Text] [Related]
17. Treatment of polycystic liver disease. Update on the management.
Aussilhou B; Dokmak S; Dondero F; Joly D; Durand F; Soubrane O; Belghiti J
J Visc Surg; 2018 Dec; 155(6):471-481. PubMed ID: 30145049
[TBL] [Abstract][Full Text] [Related]
18. Medical therapy for polycystic liver disease.
Khan S; Dennison A; Garcea G
Ann R Coll Surg Engl; 2016 Jan; 98(1):18-23. PubMed ID: 26688394
[TBL] [Abstract][Full Text] [Related]
19. Secondary, somatic mutations might promote cyst formation in patients with autosomal dominant polycystic liver disease.
Janssen MJ; Waanders E; Te Morsche RH; Xing R; Dijkman HB; Woudenberg J; Drenth JP
Gastroenterology; 2011 Dec; 141(6):2056-2063.e2. PubMed ID: 21856269
[TBL] [Abstract][Full Text] [Related]
20. Polycystic liver disease is a disorder of cotranslational protein processing.
Drenth JP; Martina JA; van de Kerkhof R; Bonifacino JS; Jansen JB
Trends Mol Med; 2005 Jan; 11(1):37-42. PubMed ID: 15649821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
